Serum Aβ Levels as Predictors of Conversion to Mild Cognitive Impairment/Alzheimer Disease in an ADAPT Subcohort

被引:13
|
作者
Abdullah, Laila [1 ]
Luis, Cheryl [1 ]
Paris, Daniel [1 ]
Mouzon, Benoit [1 ]
Ait-Ghezala, Ghania [1 ]
Keegan, Andrew P. [1 ]
Wang, Duolao [2 ]
Crawford, Fiona [1 ]
Mullan, Michael [1 ]
机构
[1] Roskamp Inst, Sarasota, FL 34243 USA
[2] London Sch Hyg & Trop Med, Med Stat Unit, London WC1, England
关键词
ALZHEIMERS-DISEASE; RISK-FACTORS; APOLIPOPROTEIN-E; DEMENTIA; HEALTH; CHOLESTEROL; MEDICATIONS; PREVENTION; STATINS; NSAIDS;
D O I
10.2119/molmed.2009.00083
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent evidence suggests an association of beta-amyloid (A beta) with vascular risk factors and the medications to treat them, which could potentially obfuscate the usefulness of A beta for prediction of mild cognitive impairment (MCI) or Alzheimer disease (AD). In a subcohort from the Alzheimer's Disease Anti-inflammatory Prevention Trial (enriched for family history of AD), we investigated whether systolic blood pressure, total cholesterol, triglycerides, serum creatinine, apolipoprotein E, and use of statins and antihypertensives influenced the predictive value of serum A beta for MCI/AD during a 2-year period. We collected blood samples to quantify serum A beta from cognitively normal participants (n = 203) at baseline and ascertained the outcome of MCI/AD (n = 24) for a period of approximately 2 years, In an unadjusted model, the lowest quartile of A beta(1-42) (hazard ratio (HR) = 2.93,95% Cl (1.02-8.32), P = 0.04) and of the A beta(1-42)/A beta(1-40) ratio (HR = 353,95% CI (1.24-10.07), P = 0.02), compared with the highest quartile, predicted conversion to MCI/AD, but no impact of A beta(1-40) was observed. No relationship between nonsteroidal antiinflammatory drug interventions and A beta on MCl/AD risk was evident. Once data were adjusted for potential confounders (age, sex, and education), vascular risk factors, and the medications listed above, the lowest quartiles of A beta(1-42) (HR = 4.47,95% Cl (1.39-14.39), P = 0.01), and of the A beta(1-42/)A beta(1-40) ratio (HR 4.87,95% CI (1.50-15.87), P = 0.01) became strong predictors of conversion to MCl/AD. In this subcohort of individuals at risk for AD, the association of All with vascular risk factors and medications to treat these conditions did not interfere with All's predictive value for MCl/AD. (C) 2009 The Feinstein Institute for Medical Research, www.feinsteininstitute.org Online address: http://www.molmed.org doi: 10.2119/molmed.2009.00083
引用
收藏
页码:432 / 437
页数:6
相关论文
共 50 条
  • [21] Assessing for Conversion to Mild Cognitive Impairment and Probable Alzheimer's Disease
    Baerresen, K. M.
    Hanson, E. R.
    Miller, K. J.
    Miller, J. S.
    Yeh, D.
    Kim, J.
    Ercoli, L. M.
    Siddarth, P.
    Small, G.
    CLINICAL NEUROPSYCHOLOGIST, 2013, 27 (04) : 540 - 540
  • [22] Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease
    Peng, SY
    Wuu, J
    Mufson, EJ
    Fahnestock, M
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (06): : 641 - 649
  • [23] Predicting conversion from mild cognitive impairment to Alzheimer's disease
    Devanand, Davangere P.
    Liu, Xinhua
    Tabert, Matthias H.
    deleon, Mony J.
    Doty, Richard L.
    Mayeux, Richard
    Stern, Yaakov
    Pelton, Gregory H.
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 102S - 102S
  • [24] Predictive models for mild cognitive impairment to Alzheimer's disease conversion
    Konstantina Skolariki
    Graciella Muniz Terrera
    Samuel O.Danso
    Neural Regeneration Research, 2021, 16 (09) : 1766 - 1767
  • [25] Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment
    Tabert, Matthias H.
    Manly, Jennifer J.
    Liu, Xinhua
    Pelton, Gregory H.
    Rosenblum, Sara
    Jacobs, Marni
    Zamora, Diana
    Goodkind, Madeleine
    Bell, Karen
    Stern, Yaakov
    Devanand, D. P.
    ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (08) : 916 - 924
  • [26] Predictive models for mild cognitive impairment to Alzheimer's disease conversion
    Skolariki, Konstantina
    Terrera, Graciella Muniz
    Danso, Samuel O.
    NEURAL REGENERATION RESEARCH, 2021, 16 (09) : 1766 - +
  • [27] Neuropsychological and Psychological Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Dementia
    Rindge, M.
    Moncrief, G.
    Daniel, M.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2017, 32 (06)
  • [28] Serial Position Effect Contrast Profiles: Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease
    Avildsen, I. K.
    Gammada, E.
    Kulkarni, A.
    Crane, P.
    Gibbons, L. E.
    Foldi, N. S.
    CLINICAL NEUROPSYCHOLOGIST, 2019, 33 (04) : 674 - 674
  • [29] The associations of serum valine with mild cognitive impairment and Alzheimer’s disease
    Yong-lan Xiong
    Joseph Therriault
    Shu-jiang Ren
    Xiao-jun Jing
    Hua Zhang
    Aging Clinical and Experimental Research, 2022, 34 : 1807 - 1817
  • [30] Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment Response
    Hansson, Oskar
    Zetterberg, Henrik
    Blennow, Kaj
    NEUROBIOLOGY OF AGING, 2010, 31 (04) : 541 - 541